55 related articles for article (PubMed ID: 21294679)
1. Organelle stress-induced activating transcription factor-3 downregulates low-density lipoprotein receptor expression in Sk-Hep1 human liver cells.
Lim JH; Lee HJ; Pak YK; Kim WH; Song J
Biol Chem; 2011 Apr; 392(4):377-85. PubMed ID: 21294679
[TBL] [Abstract][Full Text] [Related]
2. AdipoR2 is transcriptionally regulated by ER stress-inducible ATF3 in HepG2 human hepatocyte cells.
Koh IU; Lim JH; Joe MK; Kim WH; Jung MH; Yoon JB; Song J
FEBS J; 2010 May; 277(10):2304-17. PubMed ID: 20423458
[TBL] [Abstract][Full Text] [Related]
3. ATF3 negatively regulates adiponectin receptor 1 expression.
Park HJ; Kang YM; Kim CH; Jung MH
Biochem Biophys Res Commun; 2010 Sep; 400(1):72-7. PubMed ID: 20696134
[TBL] [Abstract][Full Text] [Related]
4. ATF3 represses PDX-1 expression in pancreatic β-cells.
Jang MK; Park HJ; Jung MH
Biochem Biophys Res Commun; 2011 Aug; 412(2):385-90. PubMed ID: 21821004
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of low density lipoprotein receptor expression by long-term exposure to phorbol ester via p38 mitogen-activated protein kinase pathway.
Oh J; Choi YS; Kim JW; Park JY; Kim SW; Park KK; Pak YK
J Cell Biochem; 2005 Nov; 96(4):786-94. PubMed ID: 16149074
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
7. ATF3 inhibits PDX-1-stimulated transactivation.
Kim WH; Jang MK; Kim CH; Shin HK; Jung MH
Biochem Biophys Res Commun; 2011 Nov; 414(4):681-7. PubMed ID: 21986529
[TBL] [Abstract][Full Text] [Related]
8. The induction of STAT1 gene by activating transcription factor 3 contributes to pancreatic beta-cell apoptosis and its dysfunction in streptozotocin-treated mice.
Kim JY; Song EH; Lee S; Lim JH; Choi JS; Koh IU; Song J; Kim WH
Cell Signal; 2010 Nov; 22(11):1669-80. PubMed ID: 20600850
[TBL] [Abstract][Full Text] [Related]
9. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.
Liu J; Grove RI; Vestal RE
Cell Growth Differ; 1994 Dec; 5(12):1333-8. PubMed ID: 7696181
[TBL] [Abstract][Full Text] [Related]
11. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.
Sekar N; Veldhuis JD
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783
[TBL] [Abstract][Full Text] [Related]
13. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
15. Serum response element-like sequences of the human low density lipoprotein receptor promoter: possible regulation sites for sterol-independent transcriptional activation.
Pak YK
Biochem Mol Biol Int; 1996 Feb; 38(1):31-6. PubMed ID: 8932516
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction.
Buganim Y; Kalo E; Brosh R; Besserglick H; Nachmany I; Rais Y; Stambolsky P; Tang X; Milyavsky M; Shats I; Kalis M; Goldfinger N; Rotter V
Cancer Res; 2006 Nov; 66(22):10750-9. PubMed ID: 17108111
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
James CG; Woods A; Underhill TM; Beier F
BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene.
Bottone FG; Moon Y; Alston-Mills B; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):668-77. PubMed ID: 16079301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
